Yen H.-K.SUNG-CHUN TANGLI-KAI TSAIFan S.-P.SHIN-JOE YEHJIANN-SHING JENG2021-12-222021-12-2220211028768Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85107858235&partnerID=40&md5=c9c6cb33d4eecbb4928e0598f5f4eb07https://scholars.lib.ntu.edu.tw/handle/123456789/590382Background: Treatment guideline for status epilepticus (SE) specifically in patients with anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is insufficient. This study aimed to clarify the determinants for the control of SE in adult patients wi[SDGs]SDG34 aminobutyric acid; alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid; anticonvulsive agent; azathioprine; clonazepam; cyclophosphamide; immunoglobulin; lacosamide; levetiracetam; methylprednisolone; perampanel; phenobarbital; phenytoin; pregabaliDeterminants for control of status epilepticus in patients with anti-N-methyl-D-aspartate receptor encephalitisjournal article345493952-s2.0-85107858235